# NBEAL2

## Overview
NBEAL2 is a gene that encodes the neurobeachin-like 2 protein, a member of the BEACH domain-containing protein family. This protein plays a critical role in the biogenesis and function of platelet α-granules, which are essential for normal platelet activity, including hemostasis and wound healing (GunayAygun2011NBEAL2). The neurobeachin-like 2 protein is characterized by several domains, including the BEACH, ARM, and WD40 domains, which facilitate its interactions with other proteins involved in platelet formation and immune regulation (Albers2011Exome; Mayer2018Nbeal2). Mutations in the NBEAL2 gene are linked to Gray Platelet Syndrome, a rare bleeding disorder marked by the absence of α-granules in platelets, leading to bleeding tendencies and immune dysfunction (Deppermann2013Gray; Kahr2013Abnormal). The protein's involvement in vesicular trafficking and membrane dynamics underscores its importance in maintaining cellular and organismal homeostasis (Wijgaerts2017The).

## Structure
The NBEAL2 protein is a member of the BEACH domain-containing protein family, characterized by the presence of several distinct domains, including the BEACH, ARM, and WD40 domains (GunayAygun2011NBEAL2; Albers2011Exome). The BEACH domain is approximately 35 kDa in size and features a unique hydrophobic secondary structure that does not conform to typical β-strands or random coils. It interacts strongly with the neighboring Pleckstrin Homology (PH) domain (Mayer2018Nbeal2). The WD40 domain is suggested to be involved in protein-protein interactions, potentially binding with Sec16a (Mayer2018Nbeal2).

NBEAL2 is known to interact with several proteins, including Dock7, Sec16a, and Vac14, which are crucial for its function in platelet formation and α-granule retention (Mayer2018Nbeal2). Mutations in the BEACH domain, such as P2100L and S2269L, can lead to structural changes that affect protein function (Albers2011Exome). The protein is also involved in the retention of cargo proteins within α-granules, interacting with P-selectin to stabilize these granules (Lo2018NBEAL2). The absence of NBEAL2 affects the localization and levels of Dock7, indicating its role in post-translational modification and stability (Mayer2018Nbeal2).

## Function
The NBEAL2 gene encodes the neurobeachin-like 2 protein, which is crucial for the biogenesis of platelet α-granules. These granules are essential for normal platelet function, as they store proteins that promote platelet adhesiveness, hemostasis, and wound healing (GunayAygun2011NBEAL2). In healthy human cells, particularly in megakaryocytes and platelets, NBEAL2 is involved in the proper formation and function of α-granules by localizing to the dense tubular system, a part of the endoplasmic reticulum, indicating its role in subcellular organization necessary for α-granule formation (GunayAygun2011NBEAL2).

NBEAL2 interacts with P-selectin-containing vesicles, stabilizing the contents of nascent and mature α-granules, which is crucial for the retention of cargo proteins such as von Willebrand factor and thrombospondin-1. This interaction prevents the loss of these proteins through a RAB11-mediated process, ensuring proper granule maturation (Lo2018NBEAL2). The protein's role extends to immune cell function, where it regulates CTLA-4 expression in activated conventional T cells, contributing to immune homeostasis and tolerance (Delage2023NBEAL2). NBEAL2's involvement in vesicular trafficking and membrane dynamics highlights its importance in maintaining normal cellular and organismal functions (Wijgaerts2017The).

## Clinical Significance
Mutations in the NBEAL2 gene are primarily associated with Gray Platelet Syndrome (GPS), a rare autosomal recessive bleeding disorder. GPS is characterized by macrothrombocytopenia, where patients have large platelets that lack α-granules, leading to bleeding tendencies and myelofibrosis (GunayAygun2011NBEAL2; Albers2011Exome). The absence of α-granules in platelets results in impaired storage and release of proteins essential for platelet function, such as von Willebrand factor and thrombospondin-1, which are crucial for normal hemostasis and wound healing (Deppermann2013Gray; Kahr2013Abnormal).

NBEAL2 mutations also impact immune function. Studies have shown that NBEAL2 deficiency can lead to immunological abnormalities, including increased susceptibility to infections and autoimmune manifestations such as Evans syndrome and autoimmune thyroiditis (Sowerby2017NBEAL2; Delage2023NBEAL2). NBEAL2 is involved in the regulation of CTLA-4 expression in T cells, and its deficiency is linked to immune dysregulation and autoimmunity (Delage2023NBEAL2).

Research using Nbeal2-deficient mice has provided insights into the pathophysiology of GPS, demonstrating impaired platelet function, abnormal megakaryocyte development, and defective thrombus formation, which mirror the clinical manifestations observed in human patients (Deppermann2013Gray; Kahr2013Abnormal).

## Interactions
NBEAL2 (neurobeachin-like 2) is involved in several protein interactions critical for its function in platelet formation and immune regulation. It interacts with Dock7, Sec16a, and Vac14, with the BEACH domain of NBEAL2 being crucial for binding Dock7 and Vac14, but not Sec16a, which may bind through the WD40 domain (Mayer2018Nbeal2). These interactions are essential for the proper localization and function of Dock7 in platelets, and their disruption can lead to dysregulated signaling pathways (Mayer2018Nbeal2).

NBEAL2 also interacts with P-selectin, a protein associated with α-granules, to stabilize these vesicles and prevent the loss of their cargo through a RAB11-mediated process (Lo2018NBEAL2). This interaction is crucial for the retention of cargo proteins within α-granules during their production by megakaryocytes (Lo2018NBEAL2).

In the immune system, NBEAL2 interacts with proteins involved in CTLA-4 trafficking, such as LRBA and AP1G2, suggesting a role in regulating CTLA-4 expression in T cells (Delage2023NBEAL2). These interactions highlight NBEAL2's broad functional range across different cell types, impacting both platelet function and immune regulation.


## References


[1. (Sowerby2017NBEAL2) John M. Sowerby, David C. Thomas, Simon Clare, Marion Espéli, Jose A. Guerrero, Kim Hoenderdos, Katherine Harcourt, Morgan Marsden, Juneid Abdul-Karim, Mathew Clement, Robin Antrobus, Yagnesh Umrania, Philippa R. Barton, Shaun M. Flint, Jatinder K. Juss, Alison M. Condliffe, Paul A. Lyons, Ian R. Humphreys, Edwin R. Chilvers, Willem H. Ouwehand, Gordon Dougan, and Kenneth G.C. Smith. Nbeal2 is required for neutrophil and nk cell function and pathogen defense. Journal of Clinical Investigation, 127(9):3521–3526, August 2017. URL: http://dx.doi.org/10.1172/jci91684, doi:10.1172/jci91684. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci91684)

[2. (Wijgaerts2017The) Anouck Wijgaerts, Christine Wittevrongel, Chantal Thys, Timothy Devos, Kathelijne Peerlinck, Marloes R. Tijssen, Chris Van Geet, and Kathleen Freson. The transcription factor gata1 regulates nbeal2 expression through a long-distance enhancer. Haematologica, 102(4):695–706, January 2017. URL: http://dx.doi.org/10.3324/haematol.2016.152777, doi:10.3324/haematol.2016.152777. This article has 20 citations.](https://doi.org/10.3324/haematol.2016.152777)

[3. (GunayAygun2011NBEAL2) Meral Gunay-Aygun, Tzipora C Falik-Zaccai, Thierry Vilboux, Yifat Zivony-Elboum, Fatma Gumruk, Mualla Cetin, Morad Khayat, Cornelius F Boerkoel, Nehama Kfir, Yan Huang, Dawn Maynard, Heidi Dorward, Katherine Berger, Robert Kleta, Yair Anikster, Mutlu Arat, Andrew S Freiberg, Beate E Kehrel, Kerstin Jurk, Pedro Cruz, Jim C Mullikin, James G White, Marjan Huizing, and William A Gahl. Nbeal2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nature Genetics, 43(8):732–734, July 2011. URL: http://dx.doi.org/10.1038/ng.883, doi:10.1038/ng.883. This article has 203 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.883)

[4. (Kahr2013Abnormal) Walter H. A. Kahr, Richard W. Lo, Ling Li, Fred G. Pluthero, Hilary Christensen, Ran Ni, Nima Vaezzadeh, Cynthia E. Hawkins, Andrew S. Weyrich, Jorge Di Paola, Carolina Landolt-Marticorena, and Peter L. Gross. Abnormal megakaryocyte development and platelet function in nbeal2−/− mice. Blood, 122(19):3349–3358, November 2013. URL: http://dx.doi.org/10.1182/blood-2013-04-499491, doi:10.1182/blood-2013-04-499491. This article has 94 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2013-04-499491)

[5. (Albers2011Exome) Cornelis A Albers, Ana Cvejic, Rémi Favier, Evelien E Bouwmans, Marie-Christine Alessi, Paul Bertone, Gregory Jordan, Ross N W Kettleborough, Graham Kiddle, Myrto Kostadima, Randy J Read, Botond Sipos, Suthesh Sivapalaratnam, Peter A Smethurst, Jonathan Stephens, Katrin Voss, Alan Nurden, Augusto Rendon, Paquita Nurden, and Willem H Ouwehand. Exome sequencing identifies nbeal2 as the causative gene for gray platelet syndrome. Nature Genetics, 43(8):735–737, July 2011. URL: http://dx.doi.org/10.1038/ng.885, doi:10.1038/ng.885. This article has 222 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.885)

[6. (Lo2018NBEAL2) Richard W. Lo, Ling Li, Richard Leung, Fred G. Pluthero, and Walter H.A. Kahr. Nbeal2 (neurobeachin-like 2) is required for retention of cargo proteins by α-granules during their production by megakaryocytes. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(10):2435–2447, October 2018. URL: http://dx.doi.org/10.1161/ATVBAHA.118.311270, doi:10.1161/atvbaha.118.311270. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/ATVBAHA.118.311270)

[7. (Delage2023NBEAL2) Laure Delage, Francesco Carbone, Quentin Riller, Jean-Luc Zachayus, Erwan Kerbellec, Armelle Buzy, Marie-Claude Stolzenberg, Marine Luka, Camille de Cevins, Georges Kalouche, Rémi Favier, Alizée Michel, Sonia Meynier, Aurélien Corneau, Caroline Evrard, Nathalie Neveux, Sébastien Roudières, Brieuc P. Pérot, Mathieu Fusaro, Christelle Lenoir, Olivier Pellé, Mélanie Parisot, Marc Bras, Sébastien Héritier, Guy Leverger, Anne-Sophie Korganow, Capucine Picard, Sylvain Latour, Bénédicte Collet, Alain Fischer, Bénédicte Neven, Aude Magérus, Mickaël Ménager, Benoit Pasquier, and Frédéric Rieux-Laucat. Nbeal2 deficiency in humans leads to low ctla-4 expression in activated conventional t cells. Nature Communications, June 2023. URL: http://dx.doi.org/10.1038/s41467-023-39295-7, doi:10.1038/s41467-023-39295-7. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-39295-7)

[8. (Deppermann2013Gray) Carsten Deppermann, Deya Cherpokova, Paquita Nurden, Jan-Niklas Schulz, Ina Thielmann, Peter Kraft, Timo Vögtle, Christoph Kleinschnitz, Sebastian Dütting, Georg Krohne, Sabine A. Eming, Alan T. Nurden, Beate Eckes, Guido Stoll, David Stegner, and Bernhard Nieswandt. Gray platelet syndrome and defective thrombo-inflammation in nbeal2-deficient mice. Journal of Clinical Investigation, 123(8):3331–3342, July 2013. URL: http://dx.doi.org/10.1172/jci69210, doi:10.1172/jci69210. This article has 138 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci69210)

[9. (Mayer2018Nbeal2) Louisa Mayer, Maria Jasztal, Mercedes Pardo, Salvadora Aguera de Haro, Janine Collins, Tadbir K. Bariana, Peter A. Smethurst, Luigi Grassi, Romina Petersen, Paquita Nurden, Rémi Favier, Lu Yu, Stuart Meacham, William J. Astle, Jyoti Choudhary, Wyatt W. Yue, Willem H. Ouwehand, and Jose A. Guerrero. Nbeal2 interacts with dock7, sec16a, and vac14. Blood, 131(9):1000–1011, March 2018. URL: http://dx.doi.org/10.1182/blood-2017-08-800359, doi:10.1182/blood-2017-08-800359. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2017-08-800359)